Clinical Trial Update: A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY3303560 in healthy participants and individuals with Alzheimer's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY3303560

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-09-21